<p>The invention concerns a method for assaying soluble fibrin in a sample, in which said sample is brought into the presence of a plasminogen activator with a high specificity for soluble fibrin (PA-Fb sp) and the soluble fibrin count in the sample is measured by measuring the difference between the count of fibrin degradation products obtained after degrading soluble fibrin with PA-Fb sp and the base count of fibrin degradation products determined before bringing the sample into the presence of PA-Fb sp.</p>
申请公布号
EP1313877(A1)
申请公布日期
2003.05.28
申请号
EP20010963106
申请日期
2001.08.17
申请人
SOCIETE DIAGNOSTICA-STAGO;ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS